Dataset from A Phase II, Double-blind, Placebo Controlled, Randomized Study to Assess the Efficacy and Safety of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer in Patients Who Have Failed Therapy With an Irinotecan and Fluoropyrimidine Regimen
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007704
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether treatment with ZACTIMA (vandetanib) in
combination with FOLFOX is more effective than FOLFOX alone for colorectal cancer in patients
who have failed therapy with an irinotecan and fluoropyrimidine containing regimen.
创建时间：
2024-11-26
